In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

A breakthrough in weight loss medication is on the horizon. While popular drugs like Ozempic and Wegovy are only available ... mental preparation each time. "You don't want to do that to yourself.

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

Novo CEO Lars Fruergaard Jorgensen sees Wegovy supply improving this year, and brushed off fears of the company falling behind Eli Lilly & Co. Details about its next-generation weight loss drugs ...

Weight-loss drugs will be offered to millions of people on the NHS, to help them manage their health. One jab, Wegovy ... manageable and tend to go away in time; others say they stopped taking ...

In a 72-week study, Zepbound's mean weight loss was 20.2%, while Wegovy's was 13.7%. Amycretin did better in half the time. Novo Nordisk faces at least two issues in the anti-obesity space.